Psoriasis Trial, Recruiting (NCT01706692)

Psoriasis Trial, Recruiting NCT01706692 Sponsor: Swiss Dermatology Network for Targeted Therapies Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT01706692 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with plaque psoriasis or psoriatic arthritis by a skin specialist (dermatologist)
You are 18 years of age or older
You are starting a specific biologic or systemic medication for the first time (meaning you have not taken this type of drug before)
You can read and communicate well enough in German, French, Italian, or English to give your informed consent
You are willing and able to give your consent to take part in the study

Who may not be able to join:

You are not willing or able to give your consent to participate
You are already taking part in another clinical trial at the time you would be registered for this study (note: if you join another clinical trial after joining this registry, your data will still be collected but reviewed separately)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01706692

Sponsor: Swiss Dermatology Network for Targeted Therapies

Phase: Not Applicable

Status: Recruiting

Condition: Psoriasis

More information: https://clinicaltrials.gov/study/NCT01706692

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with plaque psoriasis or psoriatic arthritis by a skin specialist (dermatologist)
You are 18 years of age or older
You are starting a specific biologic or systemic medication for the first time (meaning you have not taken this type of drug before)
You can read and communicate well enough in German, French, Italian, or English to give your informed consent
You are willing and able to give your consent to take part in the study

Who may not be able to join:

You are not willing or able to give your consent to participate
You are already taking part in another clinical trial at the time you would be registered for this study (note: if you join another clinical trial after joining this registry, your data will still be collected but reviewed separately)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Swiss Dermatology Network for Targeted Therapies

Registry

ClinicalTrials.gov

Start date

1 February 2011

Est. completion

15 March 2032

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Psoriasis Area Severity Index (PASI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov